Brief: Gc Biopharma Receives Marketing Authorization For Barycela In Vietnam
17/07/2025 07:47
July 17 (Reuters) - GC Biopharma Corp 006280.KS: RECEIVES MARKETING AUTHORIZATION FOR BARYCELA IN VIETNAM ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on GC Biopharma
See all newsBrief: Gc Biopharma Q2 Operating. Profit 1.7 Billion Won, Down 93.8% Y/Y
Brief: Gc Biopharma Corp 006280.Ks - Q1 Operating. Profit 11.7 Billion Won, Up 46% Y/Y
Brief: Green Cross Corp Q3 Operating Profit 29.2 Billion Won, Down 26.3% From Year Earlier
Brief: GC Biopharma gets CMO rights for shingles vaccine from Curevo Vaccine
Brief: Gc Biopharma Receives Marketing Authorization For Barycela In Vietnam